1. Home
  2. PAHC vs LENZ Comparison

PAHC vs LENZ Comparison

Compare PAHC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • LENZ
  • Stock Information
  • Founded
  • PAHC 1946
  • LENZ 2019
  • Country
  • PAHC United States
  • LENZ United States
  • Employees
  • PAHC N/A
  • LENZ N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • LENZ Medicinal Chemicals and Botanical Products
  • Sector
  • PAHC Health Care
  • LENZ Health Care
  • Exchange
  • PAHC Nasdaq
  • LENZ Nasdaq
  • Market Cap
  • PAHC 946.9M
  • LENZ 819.1M
  • IPO Year
  • PAHC 2014
  • LENZ 2021
  • Fundamental
  • Price
  • PAHC $24.50
  • LENZ $28.89
  • Analyst Decision
  • PAHC Sell
  • LENZ Strong Buy
  • Analyst Count
  • PAHC 4
  • LENZ 5
  • Target Price
  • PAHC $20.00
  • LENZ $41.80
  • AVG Volume (30 Days)
  • PAHC 288.4K
  • LENZ 180.2K
  • Earning Date
  • PAHC 05-07-2025
  • LENZ 05-07-2025
  • Dividend Yield
  • PAHC 1.97%
  • LENZ N/A
  • EPS Growth
  • PAHC 140.17
  • LENZ N/A
  • EPS
  • PAHC 0.78
  • LENZ N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • LENZ N/A
  • Revenue This Year
  • PAHC $28.33
  • LENZ N/A
  • Revenue Next Year
  • PAHC $13.78
  • LENZ $534.98
  • P/E Ratio
  • PAHC $31.29
  • LENZ N/A
  • Revenue Growth
  • PAHC 19.12
  • LENZ N/A
  • 52 Week Low
  • PAHC $16.16
  • LENZ $14.42
  • 52 Week High
  • PAHC $26.55
  • LENZ $38.93
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 63.39
  • LENZ 58.64
  • Support Level
  • PAHC $23.58
  • LENZ $28.51
  • Resistance Level
  • PAHC $25.26
  • LENZ $30.09
  • Average True Range (ATR)
  • PAHC 0.79
  • LENZ 1.44
  • MACD
  • PAHC 0.02
  • LENZ 0.03
  • Stochastic Oscillator
  • PAHC 62.66
  • LENZ 85.43

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: